單重免疫檢測市場規模、佔有率和成長分析:按檢測法、產品類型、目標分析物、應用、地區和產業預測,2026-2033年
市場調查報告書
商品編碼
1964320

單重免疫檢測市場規模、佔有率和成長分析:按檢測法、產品類型、目標分析物、應用、地區和產業預測,2026-2033年

Singleplex Immunoassay Market Size, Share, and Growth Analysis, By Assay Types (Enzyme-Linked Immunosorbent Assay, Lateral Flow Assay), By Product Type (Kits, Reagents), By Target Analyte, By Application, By Region - Industry Forecast 2026-2033

出版日期: | 出版商: SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

2024年全球單重免疫檢測市值為2.021億美元,預計將從2025年的2.0917億美元成長到2033年的2.7544億美元。預測期(2026-2033年)的複合年成長率預計為3.5%。

全球單重免疫檢測市場專注於針對感染疾病臨床決策所需關鍵個體生物標記的診斷測試。該市場以高分析靈敏度和完善的法規結構為特徵,鞏固了單分析物檢測在急診護理中的黃金標準地位。從手動ELISA試劑盒到自動化平台的演變,隨著主要企業不斷推動創新,處理能力和一致性得到了顯著提升。精準診斷解決方案的激增需求凸顯了單標靶檢測(例如肌鈣蛋白檢測)在改善患者管理方面的重要性。技術進步,尤其是在人工智慧領域,透過特異性試劑選擇和流程效用,正在提高檢測靈敏度和處理能力。這推動了分散式檢查的發展,展現了其在新興市場和治療監測中的持續價值。

推動全球單重免疫檢測市場發展的因素

全球單重免疫檢測市場的主要驅動力是消費者對快速、精準的診斷測試日益成長的需求,這些測試專注於檢測單一分析物。這些免疫檢測簡化了工作流程,有助於改善臨床決策並最佳化檢查室流程。它們能夠以少量檢體快速提供結果,因此在分散式和照護現場環境中備受青睞,滿足了需要即時獲得可操作資訊(例如檢測結果)的醫療專業人員的需求。這些標靶測試的效用正在提高市場接受度,促使醫院和診所採用這些測試方法,並促使供應商投資其產品供應鏈。因此,製造商正日益專注於開發和分銷這些重要的診斷工具,以滿足臨床需求。

全球單重免疫檢測市場的限制因素

專用抗體、試劑和單項分析試劑盒的高成本對全球單重免疫檢測市場構成重大挑戰。這些高成本推高了檢查室和醫療機構的單次檢測費用,可能會抑制採購,尤其是在預算有限的情況下。因此,許多機構可能會優先考慮購買多方法或整合平台,因為這些平台似乎能提供更高的單次檢測成本效益。這種經濟壓力可能會阻礙資源匱乏環境下的推廣應用,減少小規模實驗室的投資,最終限制市場成長,並促使製造商採取降低成本的策略。

全球單重免疫檢測市場趨勢

在全球單重免疫檢測市場中,工作流程整合和自動化正成為一種顯著趨勢,這主要受檢查室和照護現場環境中對易用性和快速結果的需求不斷成長的驅動。開發人員正致力於開發精簡的檢測方法和緊湊型分析儀,從而提升診斷處理能力,並提高臨床醫師的使用便利性。檢測製造商與臨床檢查室之間的策略合作進一步強化了這一趨勢,這些合作優先考慮使用者培訓以及與實驗室資訊系統的有效整合。因此,市場正在向各種醫療保健環境擴展,以支援擴充性並降低操作複雜性。

目錄

介紹

  • 調查目的
  • 市場定義和範圍

調查方法

  • 研究過程
  • 二級資料和一級資料的方法
  • 市場規模估算方法

執行摘要

  • 全球市場展望
  • 市場主要亮點
  • 細分市場概覽
  • 競爭環境概述

市場動態及展望

  • 總體經濟指標
  • 促進者和機會
  • 抑制因素和挑戰
  • 供給面趨勢
  • 需求面趨勢
  • 波特的分析和影響

市場考察

  • 關鍵成功因素
  • 影響市場的因素
  • 主要投資機會
  • 生態系測繪
  • 2025年市場吸引力指數
  • PESTEL 分析
  • 監理情勢

全球單重免疫檢測市場規模:依檢測法及複合年成長率分類(2026-2033 年)

  • 酵素免疫分析法
  • 側向流檢測法
  • 螢光免疫分析
  • 化學冷光免疫檢測

全球單重免疫檢測市場規模:依產品類型及複合年成長率分類(2026-2033 年)

  • 成套工具
  • 試劑
  • 裝置

全球單重免疫檢測市場規模:依目標分析物及複合年成長率分類(2026-2033 年)

  • 蛋白質
  • 荷爾蒙
  • 抗體
  • 病原

全球單重免疫檢測市場規模:依應用及複合年成長率分類(2026-2033 年)

  • 臨床應用
  • 研究用途
  • 醫療用途
  • 其他

全球單重免疫檢測市場規模及複合年成長率(2026-2033)

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 西班牙
    • 法國
    • 英國
    • 義大利
    • 其他歐洲地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲地區
  • 中東和非洲
    • 海灣合作理事會國家
    • 南非
    • 其他中東和非洲地區

競爭資訊

  • 前五大公司對比
  • 主要企業的市場定位(2025 年)
  • 主要市場公司採取的策略
  • 近期市場趨勢
  • 企業市佔率分析(2025 年)
  • 主要企業公司簡介
    • 公司詳情
    • 產品系列分析
    • 按細分市場進行企業市佔率分析
    • 2023-2025年營收年比比較

主要企業簡介

  • Abbott Laboratories
  • Roche Diagnostics
  • Thermo Fisher Scientific
  • Siemens Healthineers
  • Bio-Rad Laboratories
  • Ortho Clinical Diagnostics
  • PerkinElmer
  • Quidel Corporation
  • Danaher Corporation
  • Agilent Technologies
  • Merck KGaA
  • GenScript Biotech Corporation
  • Becton, Dickinson and Company
  • EMD Millipore
  • Sysmex Corporation
  • Fujifilm Wako Pure Chemical Corporation
  • Miltenyi Biotec
  • Tecan Group
  • DiaSorin SpA
  • Abcam plc

結論與建議

簡介目錄
Product Code: SQMIG35J2194

Global Singleplex Immunoassay Market size was valued at USD 202.1 Million in 2024 and is poised to grow from USD 209.17 Million in 2025 to USD 275.44 Million by 2033, growing at a CAGR of 3.5% during the forecast period (2026-2033).

The global singleplex immunoassay market focuses on diagnostic tests targeting individual biomarkers, vital for informed clinical decision-making in infectious diseases. This market is characterized by high analytical sensitivity and established regulatory frameworks, solidifying single analyte tests as the gold standard for acute care. The evolution from manual ELISA kits to automated platforms has enhanced throughput and consistency, with major players driving innovations. The demand for precise diagnostic solutions has surged, highlighting the significance of single target tests like troponin assays in improving patient management. Advancements in technology, particularly in AI, are enhancing assay sensitivity and throughput by optimizing reagent selection and automating processes. This paves the way for growth in decentralized testing, improving utility in emerging markets and therapeutic monitoring, showcasing the ongoing value of focused assays.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Singleplex Immunoassay market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Singleplex Immunoassay Market Segments Analysis

Global singleplex immunoassay market is segmented by assay types, product type, target analyte, application and region. Based on assay types, the market is segmented into Enzyme-Linked Immunosorbent Assay, Lateral Flow Assay, Fluorescent Immunoassay and Chemiluminescent Immunoassay. Based on product type, the market is segmented into Kits, Reagents and Instruments. Based on target analyte, the market is segmented into Proteins, Hormones, Antibodies and Pathogens. Based on application, the market is segmented into Clinical Applications, Research Applications, Healthcare Applications and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Singleplex Immunoassay Market

The Global Singleplex Immunoassay market is significantly influenced by the increasing demand for rapid and precise diagnostic tests that facilitate focused detection of individual analytes. These immunoassays offer straightforward workflows, enhancing clinical decision-making and optimizing laboratory processes. Their ability to work with small sample volumes and provide quicker results makes them highly favored in decentralized and point-of-care environments, catering to healthcare professionals who require immediate actionable insights. This practical relevance for targeted testing encourages hospitals and clinics to procure these assays, prompting suppliers to invest in product availability and thereby boosting market acceptance. As a result, manufacturers are increasingly focused on developing and distributing these essential diagnostic tools to address clinical requirements.

Restraints in the Global Singleplex Immunoassay Market

The high expenses related to specialized antibodies, reagents, and single-analyte assay kits present a significant challenge for the Global Singleplex Immunoassay market. These elevated costs raise the per-test expenditure for laboratories and healthcare providers, potentially deterring them from procurement, particularly when budget constraints are a factor. Consequently, many institutions may prioritize purchasing multiplex approaches or consolidated platforms that seem more cost-effective per test. This financial pressure can hinder adoption in environments with limited resources and may reduce investment from smaller laboratories, ultimately restricting market growth and influencing manufacturers to adopt strategies aimed at cost reduction.

Market Trends of the Global Singleplex Immunoassay Market

The Global Singleplex Immunoassay market is experiencing a significant trend towards workflow integration and automation, driven by a growing demand for ease of use and rapid results in both laboratory and point-of-care settings. Developers are concentrating on creating streamlined assay formats and compact analyzers, which enhance diagnostic throughput and increase accessibility for clinicians. This trend is further bolstered by strategic partnerships between assay manufacturers and clinical laboratories that prioritize user training and efficient integration with laboratory information systems. Consequently, the market is witnessing an expansion into diverse healthcare environments, supporting scalability and reducing operational complexities.

Table of Contents

Introduction

  • Objectives of the Study
  • Market Definition & Scope

Research Methodology

  • Research Process
  • Secondary & Primary Data Methods
  • Market Size Estimation Methods

Executive Summary

  • Global Market Outlook
  • Key Market Highlights
  • Segmental Overview
  • Competition Overview

Market Dynamics & Outlook

  • Macro-Economic Indicators
  • Drivers & Opportunities
  • Restraints & Challenges
  • Supply Side Trends
  • Demand Side Trends
  • Porters Analysis & Impact
    • Competitive Rivalry
    • Threat of Substitute
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers

Key Market Insights

  • Key Success Factors
  • Market Impacting Factors
  • Top Investment Pockets
  • Ecosystem Mapping
  • Market Attractiveness Index 2025
  • PESTEL Analysis
  • Regulatory Landscape

Global Singleplex Immunoassay Market Size by Assay Types & CAGR (2026-2033)

  • Market Overview
  • Enzyme-Linked Immunosorbent Assay
  • Lateral Flow Assay
  • Fluorescent Immunoassay
  • Chemiluminescent Immunoassay

Global Singleplex Immunoassay Market Size by Product Type & CAGR (2026-2033)

  • Market Overview
  • Kits
  • Reagents
  • Instruments

Global Singleplex Immunoassay Market Size by Target Analyte & CAGR (2026-2033)

  • Market Overview
  • Proteins
  • Hormones
  • Antibodies
  • Pathogens

Global Singleplex Immunoassay Market Size by Application & CAGR (2026-2033)

  • Market Overview
  • Clinical Applications
  • Research Applications
  • Healthcare Applications
  • Others

Global Singleplex Immunoassay Market Size & CAGR (2026-2033)

  • North America (Assay Types, Product Type, Target Analyte, Application)
    • US
    • Canada
  • Europe (Assay Types, Product Type, Target Analyte, Application)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Assay Types, Product Type, Target Analyte, Application)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Assay Types, Product Type, Target Analyte, Application)
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Assay Types, Product Type, Target Analyte, Application)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2025
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2025
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

  • Abbott Laboratories
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Roche Diagnostics
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Thermo Fisher Scientific
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Siemens Healthineers
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bio-Rad Laboratories
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Ortho Clinical Diagnostics
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • PerkinElmer
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Quidel Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Danaher Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Agilent Technologies
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merck KGaA
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • GenScript Biotech Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Becton, Dickinson and Company
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • EMD Millipore
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sysmex Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Fujifilm Wako Pure Chemical Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Miltenyi Biotec
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Tecan Group
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • DiaSorin S.p.A.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abcam plc
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations